These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8732200)

  • 1. Wallerian degeneration in peripheral nerve disease.
    Griffin JW; George EB; Chaudhry V
    Baillieres Clin Neurol; 1996 Mar; 5(1):65-75. PubMed ID: 8732200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wallerian degeneration in peripheral nerve disease.
    Chaudhry V; Glass JD; Griffin JW
    Neurol Clin; 1992 Aug; 10(3):613-27. PubMed ID: 1323747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Peripheral neuropathies. Current data concerning nerve regeneration (author's transl)].
    Sebille A
    Nouv Presse Med; 1982 Apr; 11(16):1206-15. PubMed ID: 6285276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wallerian degeneration as a window to peripheral neuropathy.
    Glass JD
    J Neurol Sci; 2004 May; 220(1-2):123-4. PubMed ID: 15140618
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of cytokine expression profile during Wallerian degeneration of myelinated and unmyelinated peripheral axons.
    Cheepudomwit T; Güzelsu E; Zhou C; Griffin JW; Höke A
    Neurosci Lett; 2008 Jan; 430(3):230-5. PubMed ID: 18068300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Histology and elementary pathology of the peripheral nerve].
    Vallat JM; Vallat-Decouvelaere AV
    Rev Prat; 2000 Apr; 50(7):713-8. PubMed ID: 10853549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in excitability properties associated with axonal regeneration in human neuropathy and mouse Wallerian degeneration.
    Sawai S; Kanai K; Nakata M; Hiraga A; Misawa S; Isose S; Hattori T; Kuwabara S
    Clin Neurophysiol; 2008 May; 119(5):1097-105. PubMed ID: 18342570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide in damage, disease and repair of the peripheral nervous system.
    Zochodne DW; Levy D
    Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(3):255-67. PubMed ID: 16191393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in gracile axonal dystrophy mice.
    Mi W; Beirowski B; Gillingwater TH; Adalbert R; Wagner D; Grumme D; Osaka H; Conforti L; Arnhold S; Addicks K; Wada K; Ribchester RR; Coleman MP
    Brain; 2005 Feb; 128(Pt 2):405-16. PubMed ID: 15644421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of monocyte chemoattractant protein-1, macrophage inflammatory protein-1alpha and interleukin-1beta in Wallerian degeneration.
    Perrin FE; Lacroix S; Avilés-Trigueros M; David S
    Brain; 2005 Apr; 128(Pt 4):854-66. PubMed ID: 15689362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute energy restriction triggers Wallerian degeneration in mouse.
    Alvarez S; Moldovan M; Krarup C
    Exp Neurol; 2008 Jul; 212(1):166-78. PubMed ID: 18486130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotrophins reduce degeneration of injured ascending sensory and corticospinal motor axons in adult rat spinal cord.
    Sayer FT; Oudega M; Hagg T
    Exp Neurol; 2002 May; 175(1):282-96. PubMed ID: 12009779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The method of "teasing" in morphological study of the peripheral nerve. Value in human pathology. 1-Wallerian degeneration].
    Saïd G
    Nouv Presse Med; 1974 Oct; 3(33):2101-3. PubMed ID: 4374683
    [No Abstract]   [Full Text] [Related]  

  • 14. Motor axon excitability during Wallerian degeneration.
    Moldovan M; Alvarez S; Krarup C
    Brain; 2009 Feb; 132(Pt 2):511-23. PubMed ID: 19074190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical physiopathology of axoplasmic flow].
    Nava L; Smorto MP; Piccoli F
    Riv Neurol; 1984; 54(4):274-87. PubMed ID: 6208591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axonal self-destruction and neurodegeneration.
    Raff MC; Whitmore AV; Finn JT
    Science; 2002 May; 296(5569):868-71. PubMed ID: 11988563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nature of signals that initiate the immune response during Wallerian degeneration of peripheral nerves.
    Karanth S; Yang G; Yeh J; Richardson PM
    Exp Neurol; 2006 Nov; 202(1):161-6. PubMed ID: 16828744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [MAST CELLS IN WALLERIAN DEGENERATION AND REGENERATION OF THE PERIPHERAL NERVE].
    BOSCHI E
    Sist Nerv; 1964; 16():129-39. PubMed ID: 14178271
    [No Abstract]   [Full Text] [Related]  

  • 19. Contribution of degeneration of motor and sensory fibers to pain behavior and the changes in neurotrophic factors in rat dorsal root ganglion.
    Obata K; Yamanaka H; Dai Y; Mizushima T; Fukuoka T; Tokunaga A; Yoshikawa H; Noguchi K
    Exp Neurol; 2004 Jul; 188(1):149-60. PubMed ID: 15191811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative and qualitative analysis of Wallerian degeneration using restricted axonal labelling in YFP-H mice.
    Beirowski B; Berek L; Adalbert R; Wagner D; Grumme DS; Addicks K; Ribchester RR; Coleman MP
    J Neurosci Methods; 2004 Mar; 134(1):23-35. PubMed ID: 15102500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.